News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
112,279 Results
Type
Article (1942)
Company Profile (47)
Press Release (110290)
Section
Business (42277)
Career Advice (58)
Deals (6770)
Drug Delivery (4)
Drug Development (13891)
Employer Resources (5)
FDA (2134)
Job Trends (2697)
News (63141)
Policy (3703)
Tag
Academia (218)
Accelerated approval (9)
Allergies (40)
Alliances (5254)
ALS (25)
Alzheimer's disease (179)
Antibody-drug conjugate (ADC) (71)
Approvals (2307)
Artificial intelligence (60)
Autoimmune disease (48)
Automation (3)
Bankruptcy (29)
Best Places to Work (2621)
BIOSECURE Act (1)
Biosimilars (27)
Biotechnology (33)
Bladder cancer (42)
Brain cancer (7)
Breast cancer (144)
Cancer (1037)
Cardiovascular disease (83)
Career advice (51)
CAR-T (22)
CDC (1)
Celiac Disease (1)
Cell therapy (79)
Cervical cancer (8)
Clinical research (12785)
Collaboration (207)
Compensation (171)
Complete response letters (4)
COVID-19 (331)
CRISPR (18)
C-suite (87)
Cystic fibrosis (33)
Data (1659)
Depression (26)
Dermatology (18)
Diabetes (107)
Diagnostics (1007)
Digital health (8)
Diversity, equity & inclusion (4)
Drug discovery (26)
Drug pricing (8)
Drug shortages (1)
Duchenne muscular dystrophy (54)
Earnings (34027)
Employer resources (4)
Events (16824)
Executive appointments (96)
FDA (2966)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (7)
Funding (145)
Gene editing (28)
Generative AI (4)
Gene therapy (71)
GLP-1 (152)
Government (440)
Grass and pollen (1)
Guidances (275)
Healthcare (3166)
HIV (9)
Huntington's disease (9)
IgA nephropathy (27)
Immunology and inflammation (31)
Immuno-oncology (7)
Indications (41)
Infectious disease (384)
Inflammatory bowel disease (37)
Influenza (26)
Intellectual property (26)
Interviews (9)
IPO (4796)
IRA (1)
Job creations (262)
Job search strategy (45)
JPM (2)
Kidney cancer (7)
Labor market (7)
Layoffs (24)
Legal (546)
Liver cancer (11)
Longevity (1)
Lung cancer (141)
Lymphoma (105)
Machine learning (4)
Manufacturing (92)
MASH (43)
Medical device (2351)
Medtech (2361)
Mergers & acquisitions (2200)
Metabolic disorders (258)
mRNA (9)
Multiple sclerosis (34)
NASH (2)
Neurodegenerative disease (29)
Neuropsychiatric disorders (18)
Neuroscience (387)
NextGen: Class of 2026 (791)
Non-profit (343)
Now hiring (2)
Obesity (101)
Opinion (4)
Ovarian cancer (26)
Pain (31)
Pancreatic cancer (61)
Parkinson's disease (40)
Partnered (1)
Patents (55)
Patient recruitment (76)
Peanut (14)
People (5804)
Pharmaceutical (9)
Pharmacy benefit managers (4)
Phase 1 (3466)
Phase 2 (5424)
Phase 3 (4865)
Pipeline (2318)
Policy (7)
Postmarket research (451)
Preclinical (1340)
Press Release (8)
Prostate cancer (57)
Radiopharmaceuticals (48)
Rare diseases (153)
Real estate (520)
Regulatory (3486)
Reports (13)
Research institute (221)
Resumes & cover letters (3)
Rett syndrome (5)
RNA editing (2)
RSV (19)
Schizophrenia (37)
Series A (14)
Series B (17)
Service/supplier (3)
Sickle cell disease (30)
Special edition (1)
Spinal muscular atrophy (32)
Sponsored (2)
Startups (277)
Stomach cancer (3)
Supply chain (17)
Tariffs (5)
Vaccines (136)
Venture capital (6)
Weight loss (56)
Women's health (11)
Worklife (3)
Date
Today (18)
Last 7 days (65)
Last 30 days (523)
Last 365 days (6157)
2026 (1562)
2025 (6245)
2024 (7279)
2023 (8642)
2022 (10619)
2021 (11480)
2020 (10619)
2019 (7541)
2018 (5565)
2017 (5174)
2016 (3833)
2015 (5282)
2014 (3501)
2013 (2247)
2012 (2445)
2011 (2766)
2010 (2555)
Location
Africa (51)
Alabama (8)
Alaska (1)
Arizona (30)
Arkansas (1)
Asia (6232)
Australia (3429)
California (2280)
Canada (662)
China (182)
Colorado (127)
Connecticut (78)
Delaware (82)
Europe (13742)
Florida (224)
Georgia (80)
Idaho (6)
Illinois (120)
India (6)
Indiana (253)
Iowa (1)
Japan (84)
Kansas (14)
Kentucky (5)
Louisiana (13)
Maine (14)
Maryland (256)
Massachusetts (2570)
Michigan (42)
Minnesota (249)
Mississippi (1)
Missouri (45)
Montana (3)
Nebraska (1)
Nevada (14)
New Hampshire (10)
New Jersey (880)
New York (574)
North Carolina (264)
North Dakota (1)
Northern California (1185)
Ohio (81)
Oklahoma (3)
Oregon (5)
Pennsylvania (501)
Puerto Rico (2)
South America (95)
South Carolina (2)
Southern California (986)
Tennessee (52)
Texas (225)
United States (9189)
Utah (95)
Virginia (20)
Washington D.C. (4)
Washington State (188)
West Virginia (1)
Wisconsin (19)
112,279 Results for "61".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
March 13, 2026
·
4 min read
Press Releases
Vibrant Therapeutics Raises $61M and Appoints Han Lee, Ph.D. as Co-CEO
January 12, 2026
·
5 min read
Press Releases
Nocturia Market Poised for Rapid Growth, Expected to Reach USD 7.61 Billion by 2032 | Coherent Market Insights
January 20, 2026
·
1 min read
Press Releases
Ultomiris Drug Market Size to Hit USD 48.61 Billion by 2034, Growing at a Stellar 28.5% CAGR
November 24, 2025
·
1 min read
Press Releases
vTv Therapeutics Will Participate in INNODIA Symposium at the EASD 61st Annual Meeting
September 16, 2025
·
4 min read
Press Releases
Aires Announces Record Q3/2025 Revenue of $7.4 Million and 61% YoY Sales Growth and Discusses Factors Related to Liquidity and Continuing Operations
• Gross Profit increased 73% YoY • Gross Margin increased 500 basis points to 68% • Adjusted EBITDA loss reported at $1.46M vs $1.17M in year-ago quarter • Near-term business objectives are focused on preserving cash, stabilizing operations, and securing the financial resources required to support continuity of operations
November 26, 2025
·
16 min read
Press Releases
Reprieve Cardiovascular Secures $61 Million Financing and Enrolls First Patient in Pivotal Study
August 14, 2025
·
5 min read
Press Releases
Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting
September 11, 2025
·
4 min read
Press Releases
Tendonitis Treatment Market Size to Hit USD 321.61 Billion by 2034
June 26, 2025
·
1 min read
Press Releases
Tonix Pharmaceuticals Presented an Update on Fc-modified anti-CD40L mAb, TNX-1500, at the 61st Annual Congress of the Japan Society for Transplantation
October 15, 2025
·
12 min read
1 of 11,228
Next
